Skip to content

iRadimed IRMD Financing Cash Flow

Financing Cash Flow at other companies

GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$21M+107%
Merit Medical Systems logo
Merit Medical SystemsMMSI
-$6.29M-190%
ICU Medical logo
ICU MedicalICUI
-$44.12M+21.7%
ITG
Integer HoldingsITGR
$3.83M-97.5%
Lumexa Imaging Holdings, Inc.
 logo
Lumexa Imaging Holdings, Inc. LMRI
-$5.26M-26.9%
RadNet logo
RadNetRDNT
-$17.5M-133%

Other financials

Income statement

See full
Revenue$22.0M+12.6%
Gross profit$16.8M+13.3%
Operating income$7.2M+33.2%
Net income$5.8M+24.1%
EPS (diluted)$0.45+21.6%

Balance sheet

See full
Cash & equivalents$56.4M+12.0%
Total debt$59.2K-96.9%
Total equity$98.5M+9.4%
Total assets$114.4M+12.4%

Cash flow

See full
Operating cash flow$8.3M+93.2%
CapEx$403.0K-89.1%
Free cash flow$7.9M+1,226%

Valuation

See full
Market cap$1.21B+63.4%
P/E51.3×+13.8×
P/S14×+4.2×

Profitability

See full
Gross margin76.8%-0.1pp
Operating margin32.4%+2.3pp
Net margin27.4%+1.0pp
FCF margin28.4%+8.9pp

Returns & leverage

See full
Return on equity25%+1.2pp
Debt / equity0.0×
Current ratio7.1×-1.7×

Where this comes from

Reported directly by iRadimed in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: iRadimed’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRadimed's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRadimed's financing cash flow?
iRadimed (IRMD) reported financing cash flow of -$2.61M in Q1 2026.
How has iRadimed's financing cash flow changed year-over-year?
iRadimed's financing cash flow decreased by 14.4% year-over-year, from -$2.28M to -$2.61M.
What is the long-term trend for iRadimed's financing cash flow?
Over 4 years (2021 to 2025), iRadimed's financing cash flow has grown at a 418.1% compound annual growth rate (CAGR), from $24.43K to -$17.6M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.